Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Avik, Sengupta"'
Autor:
Shuvra Shekhar Roy, Sulochana Bagri, Soujanya Vinayagamurthy, Avik Sengupta, Claudia Regina Then, Rahul Kumar, Sriram Sridharan, Shantanu Chowdhury
Publikováno v:
eLife, Vol 13 (2024)
Although the role of G-quadruplex (G4) DNA structures has been suggested in chromosomal looping this was not tested directly. Here, to test causal function, an array of G4s, or control sequence that does not form G4s, were inserted within chromatin i
Externí odkaz:
https://doaj.org/article/3bb9a3b8d61b4904ac9999874a8797a8
Publikováno v:
ACS Omega, Vol 9, Iss 16, Pp 18584-18592 (2024)
Externí odkaz:
https://doaj.org/article/32eb267e96a445789b0333c062fa99f2
Autor:
Avik Sengupta
Design and develop high-performance programs in Julia 1.0Key FeaturesLearn the characteristics of high-performance Julia codeUse the power of the GPU to write efficient numerical codeSpeed up your computation with the help of newly introduced shared
Autor:
Avik Sengupta
Design and develop high performing programs with JuliaKey Features[•]Learn to code high reliability and high performance programs[•]Stand out from the crowd by developing code that runs faster than your peers'codes[•]This book is intended for d
Deep learning-based classifier of diffuse large B-cell lymphoma cell-of-origin with clinical outcome
Autor:
Aswathi Viswanathan, Kavita Kundal, Avik Sengupta, Ambuj Kumar, Keerthana Vinod Kumar, Antony B Holmes, Rahul Kumar
Publikováno v:
Briefings in Functional Genomics. 22:42-48
Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma with poor response to R-CHOP therapy due to remarkable heterogeneity. Based on gene expression, DLBCL cases were divided into two subtypes, i.e. ABC and GCB, where AB
Autor:
Keerthana Vinod Kumar, Ambuj Kumar, Kavita Kundal, Avik Sengupta, Kunjulakshmi R, Mayilaadumveettil Nishana, Rahul Kumar
Acute myeloid leukemia (AML) is one of the leading leukemic malignancies in adults. The heterogeneity of the disease makes the diagnosis and treatment extremely difficult. Despite the significant developments and the rapid advancements in finding new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::463636c73ec287efd697d929cde010c5
https://doi.org/10.1101/2023.05.19.541403
https://doi.org/10.1101/2023.05.19.541403
Autor:
Ambuj Kumar, Keerthana Vinod Kumar, Kavita Kundal, Avik Sengupta, Kunjulakshmi R, Rahul Kumar
Multiple myeloma (MM) is a common type of blood cancer affecting plasma cells originating from the lymphoid B-cell lineage. It accounts for about 10% of all haematological malignancies and can cause significant end-organ damage. The emergence of geno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81baee72405f991457d986153612de77
https://doi.org/10.1101/2023.05.18.541396
https://doi.org/10.1101/2023.05.18.541396
Autor:
Donald C, Vinh, Jean-Philippe, Gouin, Diana, Cruz-Santiago, Michelle, Canac-Marquis, Stéphane, Bernier, Florian, Bobeuf, Avik, Sengupta, Jean-Philippe, Brassard, Alyssa, Guerra, Robert, Dziarmaga, Anna, Perez, Yichun, Sun, Yongbiao, Li, Lucie, Roussel, Mélanie J, Langelier, Danbing, Ke, Corey, Arnold, Marilyn, Whelan, Martin, Pelchat, Marc-André, Langlois, Xun, Zhang, Bruce D, Mazer
Publikováno v:
The Lancet Healthy Longevity. 3:e166-e175
The use of COVID-19 vaccines has been prioritised to protect the most vulnerable-notably, older people. Because of fluctuations in vaccine availability, strategies such as delayed second dose and heterologous prime-boost have been used. However, the
Autor:
Alexei Davydov, Artyom Putilin, Bishwarup Mondal, Apostolos Papathanassiou, Victor Sergeev, Avik Sengupta
Publikováno v:
2021 IEEE Globecom Workshops (GC Wkshps).
Autor:
Martin Pelchat, Bruce Mazer, Timothy Grant Evans, Mélanie Langelier, Yongbiao Li, Lucie Roussel, Yichun Sun, Xun Zhang, Florian Bobeuf, Stéphane Bernier, Corey Arnold, Marc-André Langlois, Michelle Canac-Marquis, Danbing Ke, Jean-Philippe Gouin, Donald C. Vinh, Diana Cruz-Santiago, Avik Sengupta, Anna Perez, Rob Dziarmaga, Alyssa Guerra, Jean-Philippe Brassard
BackgroundThe Coronavirus disease 2019 (Covid-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted accelerated vaccines development. Their use was prioritized to protect the most vulnerable, notably, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6eb5aae1fbf81d76ce2097a98a391c6
https://doi.org/10.1101/2021.09.16.21263704
https://doi.org/10.1101/2021.09.16.21263704